What cybersecurity considerations are relevant for connected ENT devices?

Connected ENT devices require robust cybersecurity measures to protect patient data and device functionality. This involves addressing risks like unauthorized access, data breaches, and ransomware attacks, often guided by standards like IEC 81001-5-1 and FDA guidance on cybersecurity in medical devices.

What kind of clinical data is typically required for ENT devices?

The required clinical data varies significantly with device classification and risk. Higher-risk devices, like cochlear implants, often require extensive pre-market clinical trials, while lower-risk devices may rely on existing literature or limited clinical data.

How does human factors engineering apply to ENT devices?

Human factors engineering, or usability engineering, is crucial for ENT devices to ensure safe and effective use. This involves designing devices that are intuitive and minimize the potential for user errors, which is particularly important for devices used in critical anatomical areas.

All terms

Market SegmentsStrategic Landscape

ENT Devices

Devices for ear, nose, and throat conditions.

Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

Definition

ENT devices include cochlear implants (Cochlear, Advanced Bionics, MED-EL), bone-anchored hearing systems, hypoglossal nerve stimulation for sleep apnea (Inspire), sinus balloons, and image-guided sinus and skull-base surgery systems. Products include cochlear implants, hearing aids, sinus devices and airway tools. FDA created an over-the-counter hearing aid category in 2022. Cochlear implants are Class III and need PMA approval.

What the regulation says

Regulators classify ENT devices based on their intended use and risk. For example, in the US, the FDA regulates these devices under 21 CFR Part 874, Ear, Nose, and Throat Devices. The EU MDR also categorizes ENT devices with classification rules outlined in Annex VIII, determining conformity assessment pathways based on invasiveness and contact with the central nervous system.

What this means in practice

Inspire's hypoglossal nerve stimulator opened a large addressable market for moderate-to-severe OSA in CPAP-intolerant patients.

Examples

A manufacturer developing a new cochlear implant must navigate Class III regulations in the US, requiring extensive pre-market approval processes and clinical trials.
A company designing a hypoglossal nerve stimulator needs to demonstrate compliance with cybersecurity standards due to its connectivity and potential for patient data access.
A firm introducing a novel sinus balloon dilation system will need to provide clinical evidence demonstrating safety and effectiveness for its intended use.

Common pitfalls

•Misclassifying an ENT device can lead to incorrect regulatory pathways and delays in market access.
•Failing to consider the unique cybersecurity risks associated with connected ENT devices can result in patient harm and non-compliance with standards like IEC 81001-5-1.
•Ignoring post-market surveillance requirements for ENT devices can lead to undetected safety issues and regulatory penalties.
•Not adequately addressing usability during the design of ENT devices can result in user error and adverse events.

Frequently asked questions

ENT devices are classified based on their intended use and risk to the patient. For instance, in the US, the FDA assigns classifications (Class I, II, or III) under specific product codes, while the EU MDR uses rules based on invasiveness and duration of use.

Grouped by theme

Editor's picks

· Hand-selected related concepts

Market Segments

Neuromodulation

Implantable devices that stimulate the nervous system to treat disease.

Latest in MedTech

Sources

4 sources

Sources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

Tier 2Regulator guidance and consensus· 1Tier 4Trade press and expert commentary· 3

Link health: 4 verified· last checked 2026-06-20· added official documents checked 2026-11-01

AAO-HNS·1MedTech Europe·1MedTech Dive·1U.S. Food and Drug Administration (FDA)·1

Inline markers like [1] jump to the matching reference above.

My progress

All terms0 / 513

Market Segments0 / 38

Saved on this device, and to your account when signed in. View studied terms

Full glossary

Browse all terms A to Z, each with a short definition.

On this term

Category: Market Segments
Sources: 4
Updated: 5/5/2026

Compare with another term

Learn in 60 seconds

Devices for ear, nose, and throat conditions.

·Inspire's hypoglossal nerve stimulator opened a large addressable market for moderate-to-severe OSA in CPAP-intolerant patients.
·Products include cochlear implants, hearing aids, sinus devices and airway tools.
·FDA created an over-the-counter hearing aid category in 2022.

Remember this

Watch out: Misclassifying an ENT device can lead to incorrect regulatory pathways and delays in market access.

Related terms

Neuromodulation

You may also need

Auto-suggested from Market Segments and shared keywords.

All Market Segments terms